Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
NKLA
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Quote Panel
Key Metrics
youtube.com
10 hours ago
youtube.com
11 hours ago
nytimes.com
12 hours ago
techcrunch.com
15 hours ago
techcrunch.com
16 hours ago
Earnings Growth
YoY
Current
Estimates
Q4.22
N/A
-11.11
vs -6.91
Q1.23
N/A
-7.81
vs -6.31
Q2.23
N/A
-6.01
vs -7.51
Q3.23
N/A
-9.01
vs -8.41
Q4.23
N/A
-3.30
vs -11.11
Q1.24
N/A
-2.70
vs -7.81
Q2.24
N/A
-2.67
vs -6.01
Q3.24
N/A
-2.75
vs -9.01
Q4.24
N/A
-2.05
vs -3.30
Q1.25
N/A
-1.83
vs -2.70
Sales Growth
YoY
Current
Estimates
Q4.22
NA
6.6M vs NA
Q1.23
+489%
11.1M vs 1.9M
Q2.23
-15%
15.4M vs 18.1M
Q3.23
-107%
-1732000.00 vs 24.2M
Q4.23
+76%
11.5M vs 6.6M
Q1.24
-33%
7.5M vs 11.1M
Q2.24
+104%
31.3M vs 15.4M
Q3.24
+1554%
25.2M vs -1732000
Q4.24
+252%
40.6M vs 11.5M
Q1.25
+471%
42.8M vs 7.5M
Return on Equity
QoQ
Q2.22
-29%
-0.29
vs -0.24
Q3.22
-42%
-0.42
vs -0.29
Q4.22
-39%
-0.39
vs -0.42
Q1.23
-31%
-0.31
vs -0.39
Q2.23
-42%
-0.42
vs -0.31
Q3.23
-71%
-0.71
vs -0.42
Q4.23
-21%
-0.21
vs -0.71
Q1.24
-25%
-0.25
vs -0.21
Q2.24
-26%
-0.26
vs -0.25
Q3.24
-53%
-0.53
vs -0.26
Institutionnal Ownership
QoQ
Q3.22
268
268
vs 264
2%
Q4.22
285
285
vs 268
6%
Q1.23
271
271
vs 285
-5%
Q2.23
272
272
vs 271
0%
Q3.23
300
300
vs 272
10%
Q4.23
305
305
vs 300
2%
Q1.24
323
323
vs 305
6%
Q2.24
178
178
vs 323
-45%
Q3.24
185
185
vs 178
4%
Q4.24
187
187
vs 185
1%
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Price Target
0.00(N/A)
Number of analyst
0
Last analyst upgrade/downgrade
Wolfe Research
initialisePrevious: Not converted
2024-04-09
Now: Peer Perform
B. Riley
initialisePrevious: Not converted
2022-09-14
Now: Buy
Loop Capital Markets
initialisePrevious: Overweight
2022-09-14
Now: Buy
Raymond James
initialisePrevious: Not converted
2022-09-14
Now: Strong Buy
Relative Strength
NKLA
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|